MMSI — Merit Medical Systems Income Statement
0.000.00%
- $4.95bn
- $5.29bn
- $1.36bn
- 92
- 39
- 65
- 73
Annual income statement for Merit Medical Systems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 964 | 1,075 | 1,151 | 1,257 | 1,357 |
| Cost of Revenue | |||||
| Gross Profit | 401 | 485 | 519 | 584 | 643 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 965 | 1,014 | 1,063 | 1,133 | 1,201 |
| Operating Profit | -1.56 | 60.9 | 87.6 | 124 | 156 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.2 | 53.9 | 82.6 | 112 | 150 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.84 | 48.5 | 74.5 | 94.4 | 120 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.84 | 48.5 | 74.5 | 94.4 | 120 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.84 | 48.5 | 74.5 | 94.4 | 120 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.474 | 1.07 | 1.44 | 1.72 | 2.14 |